Volume 2008 [110 articles]

PPARs: A Double-Edged Sword in Cancer Therapy? [50 articles]

• Peroxisome Proliferator-Activated Receptor-γ Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer, Costas Giaginis, Anna Tsantili-Kakoulidou, and Stamatios Theocharis
  Volume 2008 (2008), Article ID 431763, 12 pages
• PPAR Ligands for Cancer Chemoprevention, Yumiko Yasui, Mihye Kim, and Takuji Tanaka
  Volume 2008 (2008), Article ID 548919, 10 pages
• The Critical Role of PPARγ in Human Malignant Melanoma, Christian Freudlsperger, Udo Schumacher, Siegmar Reinert, and Jürgen Hoffmann
  Volume 2008 (2008), Article ID 503797, 5 pages
• A Role for PPARβ/δ in Tumor Stroma and Tumorigenesis, Rolf Müller, Martin Kömhoff, Jeffrey M. Peters, and Sabine Müller-Brüsselbach
  Volume 2008 (2008), Article ID 534294, 5 pages
• Anticancer Properties of PPARα-Effects on Cellular Metabolism and Inflammation, Maja Grabacka and Krzysztof Reiss
  Volume 2008 (2008), Article ID 930705, 9 pages
• PPAR-γ Thiazolidinedione Agonists and Immunotherapy in the Treatment of Brain Tumors, Terry Lichtor, Alessandra Spagnolo, Roberta P. Glick, and Douglas L. Feinstein
  Volume 2008 (2008), Article ID 547470, 4 pages
• PPARγ Inhibitors as Novel Tubulin-Targeting Agents, Katherine L. Schaefer
  Volume 2008 (2008), Article ID 785405, 9 pages
• Activation and Molecular Targets of Peroxisome Proliferator-Activated Receptor-γ Ligands in Lung Cancer, Raphael A. Nemenoff, Mary Weiser-Evans, and Robert A. Winn
  Volume 2008 (2008), Article ID 156875, 8 pages
• The Role of PPARγ in Hepatocellular Carcinoma, Ivan Borbath and Yves Horsmans
  Volume 2008 (2008), Article ID 209520, 4 pages
• Role of Peroxisome Proliferator-Activated Receptor Gamma and Its Ligands in the Treatment of Hematological Malignancies, Tatiana M. Garcia-Bates, Geniece M. Lehmann, Patricia J. Simpson-Haidaris, Steven H. Bernstein, Patricia J. Sime, and Richard P. Phipps
  Volume 2008 (2008), Article ID 834612, 18 pages
• A Role for the PPARγ in Cancer Therapy, Moray J. Campbell, Carsten Carlberg, and H. Phillip Koeffler
  Volume 2008 (2008), Article ID 314974, 17 pages
• Synergistic Effects of PPARγ Ligands and Retinoids in Cancer Treatment, Masahito Shimizu and Hisataka Moriwaki
  Volume 2008 (2008), Article ID 181047, 10 pages
• PPARγ in Neuroblastoma, Alessandro Peri, Ilaria Cellai, Susanna Benvenuti, Paola Luciani, Silvana Baglioni, and Mario Serio
  Volume 2008 (2008), Article ID 917815, 7 pages
• NO-Donating NSAIDs, PPARδ, and Cancer: Does PPARδ Contribute to Colon Carcinogenesis?, Gerardo G. Mackenzie, Shaheen Rasheed, William Wertheim, and Basil Rigas
  Volume 2008 (2008), Article ID 919572, 11 pages
• Peroxisome Proliferator-Activated Receptors and Progression of Colorectal Cancer, Dingzhi Wang and Raymond N. DuBois
  Volume 2008 (2008), Article ID 931074, 7 pages
• The Roles of Dietary PPARγ Ligands for Metastasis in Colorectal Cancer, Hiroki Kuniyasu
  Volume 2008 (2008), Article ID 529720, 7 pages
• Screening for PPAR Responsive Regulatory Modules in Cancer, Merja Heinäniemi and Carsten Carlberg
  Volume 2008 (2008), Article ID 749073, 8 pages
• Multiple Interactions between Peroxisome Proliferators-Activated Receptors and the Ubiquitin-Proteasome System and Implications for Cancer Pathogenesis, Davide Genini, Giuseppina M. Carbone, and Carlo V. Catapano
  Volume 2008 (2008), Article ID 195065, 11 pages
• A Role for PPARγ in the Regulation of Cytokines in Immune Cells and Cancer, Xiao Yi Yang, Li Hua Wang, and William L. Farrar
  Volume 2008 (2008), Article ID 961753, 12 pages
• PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate, Robert I. Glazer, Hongyan Yuan, Zhihui Xie, and Yuzhi Yin
  Volume 2008 (2008), Article ID 247379, 8 pages
• The Role of PPARs in Cancer, Keisuke Tachibana, Daisuke Yamasaki, Kenji Ishimoto, and Takefumi Doi
  Volume 2008 (2008), Article ID 102737, 15 pages
• PPARγ and MEK Interactions in Cancer, Elke Burgermeister and Rony Seger
  Volume 2008 (2008), Article ID 309469, 16 pages
• The Role of PPAR-γ and Its Interaction with COX-2 in Pancreatic Cancer, Guido Eibl
  Volume 2008 (2008), Article ID 326915, 6 pages
• PPARγ and Apoptosis in Cancer, Heath A. Elrod and Shi-Yong Sun
  Volume 2008 (2008), Article ID 704165, 12 pages
• A Novel Mechanism of PPARγ Regulation of TGFβ1: Implication in Cancer Biology, Chang Ho Lee, Hyung Don Kim, Sang Mi Shin, and Sang Geon Kim
  Volume 2008 (2008), Article ID 762398, 10 pages
• Macrophages, PPARs, and Cancer, Jo A. Van Ginderachter, Kiavash Movahedi, Jan Van den Bossche, and Patrick De Baetselier
  Volume 2008 (2008), Article ID 169414, 11 pages
• Pathophysiological Roles of PPARγ in Gastrointestinal Epithelial Cells, Brian M. Necela and E. Aubrey Thompson
  Volume 2008 (2008), Article ID 148687, 8 pages
• Do PPARγ Ligands Suppress the Growth of Cholangiocarcinoma or the Cholangiohepatitis Induced by the Tumor?, Satoru Suzuki and Kiyoshi Hashizume
  Volume 2008 (2008), Article ID 587401, 4 pages
• Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?, Roberto Scatena, Patrizia Bottoni, and Bruno Giardina
  Volume 2008 (2008), Article ID 256251, 10 pages
• PPAR Ligands as Potential Modifiers of Breast Carcinoma Outcomes, Ancha Baranova
  Volume 2008 (2008), Article ID 230893, 10 pages
• Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling, Giulia Cantini, Adriana Lombardi, Elisabetta Piscitelli, Giada Poli, Elisabetta Ceni, Sara Marchiani, Tonino Ercolino, Andrea Galli, Mario Serio, Massimo Mannelli, and Michaela Luconi
  Volume 2008 (2008), Article ID 904041, 11 pages
• PPARγ and Proline Oxidase in Cancer, James M. Phang, Jui Pandhare, Olga Zabirnyk, and Yongmin Liu
  Volume 2008 (2008), Article ID 542694, 9 pages
• Role of Peroxisome Proliferator-Activated Receptor Alpha in the Control of Cyclooxygenase 2 and Vascular Endothelial Growth Factor: Involvement in Tumor Growth, Raquel Grau, Manuel D. Díaz-Muñoz, Cristina Cacheiro-Llaguno, Manuel Fresno, and Miguel A. Iñiguez
  Volume 2008 (2008), Article ID 352437, 10 pages
• Activated PPARγ Targets Surface and Intracellular Signals That Inhibit the Proliferation of Lung Carcinoma Cells, Shou Wei Han and Jesse Roman
  Volume 2008 (2008), Article ID 254108, 8 pages
• PPARα Ligands as Antitumorigenic and Antiangiogenic Agents, Ambra Pozzi and Jorge H. Capdevila
  Volume 2008 (2008), Article ID 906542, 8 pages
• Peroxisome Proliferator-Activated Receptors (PPARs) as Potential Inducers of Antineoplastic Effects in CNS Tumors, Lars Tatenhorst, Eric Hahnen, and Michael T. Heneka
  Volume 2008 (2008), Article ID 204514, 9 pages
• Chondrosarcoma and Peroxisome Proliferator-Activated Receptor, K. Nishida, T. Kunisada, Z. N. Shen, Y. Kadota, K. Hashizume, and T. Ozaki
  Volume 2008 (2008), Article ID 250568, 7 pages
• Omega-3 Fatty Acids and PPARγ in Cancer, Iris J. Edwards and Joseph T. O'Flaherty
  Volume 2008 (2008), Article ID 358052, 14 pages
• The Role of PPARγ in the Cyclooxygenase Pathway in Lung Cancer, Saswati Hazra, Katherine A. Peebles, Sherven Sharma, Jenny T. Mao, and Steven M. Dubinett
  Volume 2008 (2008), Article ID 790568, 7 pages
• PPARα- and DEHP-Induced Cancers, Yuki Ito and Tamie Nakajima
  Volume 2008 (2008), Article ID 759716, 12 pages
• CXCR4 in Cancer and Its Regulation by PPARγ, Cynthia Lee Richard and Jonathan Blay
  Volume 2008 (2008), Article ID 769413, 19 pages
• Potential of Peroxisome Proliferator-Activated Receptor Gamma Antagonist Compounds as Therapeutic Agents for a Wide Range of Cancer Types, Jack D. Burton, David M. Goldenberg, and Rosalyn D. Blumenthal
  Volume 2008 (2008), Article ID 494161, 7 pages
• PPARγ: The Portrait of a Target Ally to Cancer Chemopreventive Agents, Ioannis Sainis, Katerina Vareli, Vasilios Karavasilis, and Evangelos Briasoulis
  Volume 2008 (2008), Article ID 436489, 10 pages
• To Live or to Die: Prosurvival Activity of PPARγ in Cancers, Y. Lynn Wang and Qi Miao
  Volume 2008 (2008), Article ID 209629, 13 pages
• PPAR Gamma Activators: Off-Target Against Glioma Cell Migration and Brain Invasion, Sebastian Seufert, Roland Coras, Christian Tränkle, Darius P. Zlotos, Ingmar Blümcke, Lars Tatenhorst, Michael T. Heneka, and Eric Hahnen
  Volume 2008 (2008), Article ID 513943, 7 pages
• Rosiglitazone Suppresses the Growth and Invasiveness of SGC-7901 Gastric Cancer Cells and Angiogenesis In Vitro via PPARγ Dependent and Independent Mechanisms, Qing He, Ruiping Pang, Xin Song, Jie Chen, Huixin Chen, Baili Chen, Pinjin Hu, and Minhu Chen
  Volume 2008 (2008), Article ID 649808, 9 pages
• The Role of the PAX8/PPARγ Fusion Oncogene in Thyroid Cancer, Kimberly A. Placzkowski, Honey V. Reddi, Stefan K. G. Grebe, Norman L. Eberhardt, and Bryan McIver
  Volume 2008 (2008), Article ID 672829, 10 pages
• Potential Therapeutic Use of PPARγ-Programed Human Monocyte-Derived Dendritic Cells in Cancer Vaccination Therapy, Adrienn Gyöngyösi and László Nagy
  Volume 2008 (2008), Article ID 473804, 10 pages
• PPARγ and Agonists against Cancer: Rational Design of Complementation Treatments, Dorina Veliceasa, Frank Thilo Schulze-Hoëpfner, and Olga V. Volpert
  Volume 2008 (2008), Article ID 945275, 13 pages
• The Role of PPARs in the Endothelium: Implications for Cancer Therapy, David Bishop-Bailey and Karen E. Swales
  Volume 2008 (2008), Article ID 904251, 12 pages